Shingrix Vaccination After Incomplete Series
If someone received only one dose of Shingrix (recombinant zoster vaccine) 2 years ago, they should receive the second dose as soon as possible to complete the series without restarting the entire series. 1, 2
Rationale for Completing the Series
The Advisory Committee on Immunization Practices (ACIP) and CDC guidelines clearly indicate that:
- The standard Shingrix vaccination schedule consists of two doses (0.5 mL each) administered 2-6 months apart 2
- There is no maximum interval between doses - if the second dose is delayed, it should still be administered as soon as possible without restarting the series 1
- Completing the full two-dose series is crucial for optimal protection 2, 3
Effectiveness of Complete vs. Incomplete Series
Real-world effectiveness data strongly supports completing the series:
- Two-dose effectiveness: 70.1% (95% CI, 68.6-71.5) 3
- One-dose effectiveness: 56.9% (95% CI, 55.0-58.8) 3
This significant difference in effectiveness (approximately 13% higher with two doses) underscores the importance of completing the full series, even when the second dose is delayed beyond the recommended 2-6 month interval.
Administration Guidelines
When administering the delayed second dose:
- No need to restart the series regardless of the time elapsed since the first dose 1
- Administer the second dose subcutaneously in the deltoid region 2
- The vaccine can be given simultaneously with other vaccines if needed (such as influenza or pneumococcal vaccines) 2
Special Considerations
Immunocompromised Patients
- For immunocompromised adults, a shortened dosing interval of 1-2 months between doses is recommended 2
- Even with delayed administration, the second dose remains effective in immunocompromised individuals 2
Previous Zoster Episode
- Having had a previous episode of herpes zoster is not a contraindication to completing the Shingrix series 1, 2
- In fact, vaccination is recommended to prevent future episodes once the acute episode has completely resolved 2
Common Pitfalls to Avoid
Restarting the series unnecessarily: There is no maximum interval after which the series must be restarted - simply administer the second dose as soon as possible 1
Assuming one dose provides sufficient protection: While one dose provides some protection (56.9% effectiveness), completing the series significantly improves effectiveness to 70.1% 3
Delaying the second dose indefinitely: Although there's no maximum interval, unnecessary delay should be avoided as the patient remains suboptimally protected until the series is completed 2
Confusing recommendations between Shingrix and the older Zostavax vaccine: Unlike the older live zoster vaccine (Zostavax), Shingrix requires two doses for optimal effectiveness 2, 4
In conclusion, for someone who received one dose of Shingrix 2 years ago, the clear recommendation is to administer the second dose as soon as possible without restarting the series, regardless of the extended interval since the first dose.